Skip to content

Bright Light Therapy for Adolescent Depression

Bright Light Therapy for Adolescent Depression: Effects on Sleep and Mental Health

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621001693819
Enrollment
5
Registered
2021-12-10
Start date
2022-09-02
Completion date
2023-10-09
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The current study aims to evaluate to what extent inclusion of bright light therapy as an adjunct to the treatment for depression, improves sleep and mental health outcomes for young people with depression.

Interventions

Bright Light Therapy Participants allocated to receive Bright Light Therapy will be given basic (age appropriate) information (designed for this study) regarding sleep and the circadian rhythm. Treatment will involve individualised behavioural instructions, including how and when to use the Re-timer glasses and when to avoid bright light in the evening. The participants will be instructed to wear Re-Timer bright light glasses for between 30-60 minutes daily, for three weeks total. Behavioural in

Bright Light Therapy Participants allocated to receive Bright Light Therapy will be given basic (age appropriate) information (designed for this study) regarding sleep and the circadian rhythm. Treatment will involve individualised behavioural instructions, including how and when to use the Re-timer glasses and when to avoid bright light in the evening. The participants will be instructed to wear Re-Timer bright light glasses for between 30-60 minutes daily, for three weeks total. Behavioural instructions will differ for each participant, depending on the severity of sleep timing delay and desired bed and wake up times. Wake up times will be advanced by half an hour each morning until a wake up time of 6am is achieved (bright light therapy treatment sessions 1 and 2). Any issues that arise, regarding treatment implementation (e.g., social obligations conflicting with treatment etc.), can be discussed with the psychologist in bright light therapy treatment sessions 2 and 3. Once this desired wake up time is achieved, a period of consolidation will occur, where the participant maintains a consistent sleep schedule (e.g., set bed times and wake up times), whilst still using the bright light glasses (bright light therapy treatment session 2 and 3), and relapse prevention instructions will be provided (bright light therapy treatment session 3). Brief Behavioural Activation for Adolescent Depression Brief behavioural activation (Brief BA) for adolescent depression is a low-intensity, brief, structured behavioural intervention that can be delivered by a range of healthcare professionals (Pass, Lejuez & Reynolds, 2017). Brief BA is delivered over 8 1-hour sessions across 6 weeks (separate from bright light therapy sessions, yet commencing immediately after completion of the 3 week bright light therapy intervention/ sleep monitoring). Psychologists work with adolescents and their parent, following a structured workbook. Brief BA involves identifying how young people spend their time (activity monitoring) and what matters most to them (i.e., their values). This information is then used to schedule valued activities into the young person’s daily life, to increase rewarding experiences. Adolescents will complete an activity log out of session (approx. 10 mins daily, returned in session) and will complete valued activities (duration will vary per participant). Participants will be randomly allocated to receive either bright light therapy plus brief behavioural activation or brief behavioural activation alone. Whilst participants in the bright light therapy (BLT) group receive undergo BLT (3 weeks), participants in the brief behavioural activation alone group will monitor their sleep. Treatment will be delivered online via videoconferencing.

Sponsors

University of Western Australia
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Meet diagnostic criteria for Major or Persistent Depressive Disorder.

Exclusion criteria

Individuals will be ineligible to participate if they have Bipolar Disorder, unmanaged psychotic symptoms, a history of seizure disorder and/or if they have vision problems (i.e., no light perception, glaucoma). To minimise risk, individuals who are actively suicidal and/or are in physically or sexually abusive environments will not be eligible to participate.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026